Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects

Cat peptide antigen desensitisation for treating cat allergic rhinoconjunctivitis

(2013) Margitta Worm et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy

(2013) Menno A. Kiel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

(2012) Stephen R. Durham et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Fel d 1–derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study

(2012) Deepen Patel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy

(2012) Lars Jacobsen et al.   Clinical and Translational Allergy

Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy

(2011) Margitta Worm et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Human allergy to environmental pet danders: a public health perspective

(2010) Daniel O. Morris   VETERINARY DERMATOLOGY